Posts Tagged :

Payer Access

Pharmacist-Driven Program for Evaluation of Pneumococcal Vaccination Among Adult Patients with Cystic Fibrosis 216 115 Shields Health Solutions

Pharmacist-Driven Program for Evaluation of Pneumococcal Vaccination Among Adult Patients with Cystic Fibrosis

This study highlights why engaging with a pharmacist during clinic visits facilitates appropriate immunization and supports adult patients with cystic fibrosis (PwCF).  

Evaluation of Pharmacist-Led Clinical Interventions for Mavacamten within an Integrated Health System Specialty Pharmacy Care Model 216 115 Shields Health Solutions

Evaluation of Pharmacist-Led Clinical Interventions for Mavacamten within an Integrated Health System Specialty Pharmacy Care Model

This study explores how a pharmacist-led mavacamten clinical management program ensures proactive management and identification of clinical and safety issues for patients on this complex therapy, as demonstrated by clinical…

The Hidden Value of Integrated Specialty Pharmacy Partnership 1024 576 Shields Health Solutions

The Hidden Value of Integrated Specialty Pharmacy Partnership

Health systems build business cases for specialty pharmacy around predictable benefits: revenue retention, 340B optimization, and continuity of patient care. But the most significant impacts rarely appear in initial ROI…

Revenue and Patient Volume Associated with Accreditation Restricted Limited Distribution Drugs in Health System Specialty Pharmacies 216 115 Shields Health Solutions

Revenue and Patient Volume Associated with Accreditation Restricted Limited Distribution Drugs in Health System Specialty Pharmacies

    Accreditation positions health system specialty pharmacies to expand access to high-value medications and supports integrated caremodels shown to reduce healthcare costs.  

Ambulatory Clinical Pharmacist Impact on Coverage Determinations for Specialty Oncology Medications 216 115 Shields Health Solutions

Ambulatory Clinical Pharmacist Impact on Coverage Determinations for Specialty Oncology Medications

    This poster evaluates the impact of an ambulatory clinical pharmacist (ACP) program on third party pharmacy coverage determinationoutcomes for specialty oncology medications prescribed from these clinics.  

The Impact of Re-Training Specialty Pharmacy Outreach Technicians and Optimizing Compliance and Productivity 216 115 Shields Health Solutions

The Impact of Re-Training Specialty Pharmacy Outreach Technicians and Optimizing Compliance and Productivity

  This poster assesses the impact of re-training for specialty pharmacy outreach technicians by evaluating improvements in compliance knowledge, technician productivity, and patient enrollment rates.  

Pharmacist Impact on Coverage Outcomes in Oncology 216 115 Shields Health Solutions

Pharmacist Impact on Coverage Outcomes in Oncology

This poster examines how remote placement of an ambulatory clinical pharmacist alongside a pharmacy liaison improved approval rates for specialty oncology medication PAs and appeals, suggesting potential benefits for other…

Value of Shields to Payers 204 115 Shields Health Solutions

Value of Shields to Payers

Shields solutions help payers elevate plan insights, outcomes and performance.

Value of Shields to Health Systems 204 115 Shields Health Solutions

Value of Shields to Health Systems

Shields partners with health system leaders to transform their specialty pharmacies into powerful growth engines and measurably improve patient outcomes throughout their health systems.

Value of Shields to Drug Manufacturers 204 115 Shields Health Solutions

Value of Shields to Drug Manufacturers

Shields offers a unique collection of solutions that allow pharma manufacturers to elevate awareness, engagement and insights through the Shields Health System Network.